The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
The K1 Capsular Polysaccharide of Acinetobacter baumannii Strain 307-0294 Is a Major Virulence Factor
Open accessAbstract
Acinetobacter baumannii is a pathogen of increasing medical importance with a propensity to be multidrug resistant, thereby making treatment challenging. Little is known of virulence traits in A. baumannii . To identify virulence factors and potential drug targets, random transposon (Tn) mutants derived from the A. baumannii strain AB307-0294 were screened to identify genes essential for growth in human ascites fluid in vitro , an inflammatory exudative fluid. These studies led to the identification of two genes that were predicted to be required for capsule polymerization and assembly. The first, ptk , encodes a putative protein tyrosine kinase (PTK), and the second, epsA , encodes a putative polysaccharide export outer membrane protein (EpsA). Monoclonal antibodies used in flow cytometric and Western analyses confirmed that these genes are required for a capsule-positive phenotype. A capsule-positive phenotype significantly optimized growth in human ascites fluid, survival in human serum, and survival in a rat soft tissue infection model. Importantly, the clearance of the capsule-minus mutants AB307.30 ( ptk mutant, capsule minus) and AB307.45 ( epsA mutant, capsule minus) was complete and durable. These data demonstrated that the K1 capsule from AB307-0294 was an important protectin. Further, these data suggested that conserved proteins, which contribute to the capsule-positive phenotype, are potential antivirulence drug targets. Therefore, the results from this study have important biologic and translational implications and, to the best of our knowledge, are the first to address the role of capsule in the pathogenesis of A. baumannii infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Acinetobacter baumannii : Emergence of a Successful Pathogen
Peleg, A. Y., Seifert, H., & Paterson, D. L. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-07 · Cited by 3,316
Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features
Bergogne-Bérézin, E., & Towner, K. J. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.2.148 · Cited by 1,711
Overview of Nosocomial Infections Caused by Gram-Negative Bacilli
Weinstein, R. A., Gaynes, R., Edwards, J. R., & System, N. N. I. S. (2005) · Clinical Infectious Diseases · doi:10.1086/432803 · Cited by 1,404 · cited 2×
“The incidence of Acinetobacter baumannii infection in all venues is increasing worldwide (17, 20, 32, 34).”
BackgroundThe Epidemiology and Control of Acinetobacter baumannii in Health Care Facilities
Fournier, P. E., Richet, H., & Weinstein, R. A. (2006) · Clinical Infectious Diseases · doi:10.1086/500202 · Cited by 995
Haine, M. M.-L., & Meeùs, N. (1986) · Cited by 879
Targeting QseC Signaling and Virulence for Antibiotic Development
Rasko, D. A., Moreira, C. G., Li, D. R., Reading, N. C., Ritchie, J. M., Waldor, M. K., Williams, N., Taussig, R., Wei, S., Roth, M., et al. (2008) · Science · doi:10.1126/science.1160354 · Cited by 519
Comparative Genome Sequence Analysis of Multidrug-Resistant Acinetobacter baumannii
Adams, M. D., Goglin, K., Molyneaux, N., Hujer, K. M., Lavender, H., Jamison, J. J., MacDonald, I. J., Martin, K. M., Russo, T., Campagnari, A. A., et al. (2008) · Journal of Bacteriology · doi:10.1128/jb.00834-08 · Cited by 435
Self-citationAcinetobacter Outbreaks, 1977–2000
Villegas, M. V., & Hartstein, A. I. (2003) · Infection Control & Hospital Epidemiology · doi:10.1086/502205 · Cited by 402
Scott, P., Deye, G., Srinivasan, A., Murray, C., Moran, K., Hulten, E., Fishbain, J., Craft, D., Riddell, S., Lindler, L., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/518170 · Cited by 393
Choi, A. H. K., Slamti, L., Avci, F. Y., Pier, G. B., & Maira-Litrán, T. (2009) · Journal of Bacteriology · doi:10.1128/jb.00647-09 · Cited by 387
Wza the translocon for E. coli capsular polysaccharides defines a new class of membrane protein
Dong, C., Beis, K., Nesper, J., Brunkan-LaMontagne, A. L., Clarke, B. R., Whitfield, C., & Naismith, J. H. (2006) · Nature · doi:10.1038/nature05267 · Cited by 373
Antimicrobial resistance of Acinetobacter spp. in Europe
Van Looveren, M., & Goossens, H. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.00942.x · Cited by 327
Multidrug-Resistant Acinetobacter Extremity Infections in Soldiers
Davis, K. A., Moran, K. A., McAllister, C. K., & Gray, P. J. (2005) · Emerging Infectious Diseases · doi:10.3201/1108.050103 · Cited by 327
Cuthbertson, L., Mainprize, I. L., Naismith, J. H., & Whitfield, C. (2009) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00024-08 · Cited by 300
Identification and Characterization of an Acinetobacter baumannii Biofilm-Associated Protein
Loehfelm, T. W., Luke, N. R., & Campagnari, A. A. (2008) · Journal of Bacteriology · doi:10.1128/jb.01416-07 · Cited by 279
Self-citationInfectious Complications of Open Type III Tibial Fractures among Combat Casualties
Johnson, E. N., Burns, T. C., Hayda, R. A., Hospenthal, D. R., & Murray, C. K. (2007) · Clinical Infectious Diseases · doi:10.1086/520029 · Cited by 276
Multidrug-Resistant Acinetobacter Infections: An Emerging Challenge to Clinicians
Jain, R., & Danziger, L. H. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d592 · Cited by 219
Severe Community-Acquired Pneumonia due to Acinetobacter baumannii
Chen, M.-Z., Hsueh, P.-R., Lee, L.-N., Yu, C.-J., Yang, P.-C., & Luh, K.-T. (2001) · Chest · doi:10.1378/chest.120.4.1072 · Cited by 186
Community-Acquired Acinetobacter Pneumonia in the Northern Territory of Australia
Anstey, N. M., Currie, B. J., & Withnall, K. M. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.1.83 · Cited by 176
Desperately Seeking New Antibiotics
Payne, D. J. (2008) · Science · doi:10.1126/science.1164586 · Cited by 160
Collins, R. F., Beis, K., Dong, C., Botting, C. H., McDonnell, C., Ford, R. C., Clarke, B. R., Whitfield, C., & Naismith, J. H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607763104 · Cited by 152
Anstey, N. M., Currie, B. J., Hassell, M., Palmer, D., Dwyer, B., & Seifert, H. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.2.685-686.2002 · Cited by 146
Maegele, M., Gregor, S., Steinhausen, E. S., Bouillon, B., Heiss, M. M., Perbix, W., Wappler, F., Rixen, D., Geisen, J., Berger-Schreck, B., et al. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000163269.42524.50 · Cited by 121
Luke, N. R., Sauberan, S. L., Russo, T. A., Beanan, J. M., Olson, R., Loehfelm, T. W., Cox, A. D., St. Michael, F., Vinogradov, E. V., & Campagnari, A. A. (2010) · Infection and Immunity · doi:10.1128/iai.00016-10 · Cited by 114 · cited 6×
“45 were defective in capsule expression and not lipopolysaccharide (LPS), we performed additional studies with the recently described MAb 13C11 and LPS core mutant AB307::Tn17 (27).”
BackgroundMethodInfluentialSelf-citationRusso, T. A., MacDonald, U., Beanan, J. M., Olson, R., MacDonald, I. J., Sauberan, S. L., Luke, N. R., Schultz, L. W., & Umland, T. C. (2009) · The Journal of Infectious Diseases · doi:10.1086/596317 · Cited by 105
Self-citationFalagas, M. E., & Karveli, E. A. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01596.x · Cited by 99
Atypical Infections in Tsunami Survivors
Garzoni, C., Emonet, S., Legout, L., Benedict, R., Hoffmeyer, P. J., Bernard, L., & Garbino, J. (2005) · Emerging infectious diseases · doi:10.3201/eid1110.050715 · Cited by 93
Robenshtok, E., Paul, M., Leibovici, L., Fraser, A., Pitlik, S. D., Ostfeld, I., Samra, Z., Perez, S., Lev, B., & Weinberger, M. (2006) · Journal of Hospital Infection · doi:10.1016/j.jhin.2006.06.025 · Cited by 86
Nakar, D., & Gutnick, D. L. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.3.1001-1009.2003 · Cited by 80
van der Ley, P., Kuipers, O. P., Tommassen, J., & Lugtenberg, B. J. J. (1986) · Microbial Pathogenesis · doi:10.1016/0882-4010(86)90030-6 · Cited by 76
Nosocomial Infections Caused by Acinetobacter baumannii A Major Threat Worldwide
Richet, H., & Fournier, P. (2006) · Infection Control and Hospital Epidemiology · doi:10.1086/505900 · Cited by 73
Campagnari, A. A., Ducey, T. F., & Rebmann, C. A. (1996) · Infection and Immunity · doi:10.1128/iai.64.9.3920-3924.1996 · Cited by 64
Self-citationRat Pneumonia and Soft-Tissue Infection Models for the Study of Acinetobacter baumannii Biology
Russo, T. A., Beanan, J. M., Olson, R., MacDonald, U., Luke, N. R., Gill, S. R., & Campagnari, A. A. (2008) · Infection and Immunity · doi:10.1128/iai.00269-08 · Cited by 62
Self-citationDoublet, P., Vincent, C., Grangeasse, C., Cozzone, A. J., & Duclos, B. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00111-8 · Cited by 44
Russo, T. A., Beanan, J. M., Olson, R., Genagon, S. A., MacDonald, U., Cope, J. J., Davidson, B. A., Johnston, B., & Johnson, J. R. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.100 · Cited by 38
Self-citation
Cited by
Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges
Wong, D., Nielsen, T. B., Bonomo, R. A., Pantapalangkoor, P., Luna, B., & Spellberg, B. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-16 · Cited by 1,170
Uncovering the mechanisms of Acinetobacter baumannii virulence
Harding, C. M., Hennon, S. W., & Feldman, M. F. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.148 · Cited by 1,026
Lee, C.-R., Lee, J. H., Park, M., Park, K. S., Bae, I. K., Kim, Y. B., Cha, C.-J., Jeong, B. C., & Lee, S. H. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00055 · Cited by 1,016
Acinetobacter baumannii: evolution of a global pathogen
Antunes, L. C. S., Visca, P., & Towner, K. J. (2014) · Pathogens and Disease · doi:10.1111/2049-632x.12125 · Cited by 925
Antibiotic Modulation of Capsular Exopolysaccharide and Virulence in Acinetobacter baumannii
Geisinger, E., & Isberg, R. R. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004691 · Cited by 548
Metadata
- Authors
- Russo, T. A., Luke, N. R., Beanan, J. M., Olson, R., Sauberan, S. L., MacDonald, U., Schultz, L. W., Umland, T. C., & Campagnari, A. A.
- Venue
- Infection and Immunity
- Publisher
- American Society for Microbiology
- Published
- 2010-09
- Volume
- 78
- Issue
- 9
- Pages
- 3993-4000
- ISSN
- 0019-9567 (ISSN-L)
- 1098-5522
- OpenAlex
- W1986622235
- Cited by
- 324
- References
- 36
- FWCI
- 6.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.